awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34531545-E7660F65-AF68-4FE6-A1BC-B54D0B8889D2
Q34531545-E7660F65-AF68-4FE6-A1BC-B54D0B8889D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34531545-E7660F65-AF68-4FE6-A1BC-B54D0B8889D2
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
P2860
Q34531545-E7660F65-AF68-4FE6-A1BC-B54D0B8889D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34531545-E7660F65-AF68-4FE6-A1BC-B54D0B8889D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae89cfc195954b9ca5b1f8fe97f1e616eed83c99
P2860
Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.